Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
We have all been involved in cases regarding inventorship. Some of these situations can be either tricky or can be solved in a more fact-based manner. Research staff often don't know the difference between a co-author of an article and a co-inventor. This webinar drills down into the details of Defining Inventorship.
Are we also listening to the researchers? Do we really know what they think about our way of working? How do they perceive the information they get from us? Both presenters have been involved in knowledge transfer and commercialisation who share their views and impressions of the knowledge transfer process with us.
ASTP, AUTM, KCA and PraxisAuril have proposed a definition of the profession and discussed it with ATTP. It is our ambition that further development of this should be managed through the custodianship of ATTP. Its partnership of national associations of KE/TT gives it a unique global view which will help uncover new activities in the profession and enable it to support new education programs and certification.
The development of new and improved varieties of plants benefits the economy by increasing the marketability of crops and improving rural income and overall economic development.
The ASTP Annual Survey provides an unique view of the European knowledge transfer landscape. We are pleased to share the results of the survey conducted on financial year 2018 data.
Released by the EPO and the EUIPO, this study shows that companies which own at least one patent, registered design or trade mark generate on average 20% higher revenues per employee than companies which do not own any of those intellectual property rights (IPRs).
Most KTOs work with the spin-out route as a way of commercialising inventions from our research institutions: there are different models and policies in place at different KTOs. Marjan Kraak (Head of Spin-Off Group, ETH Transfer at ETH Zurich) take us through ETH Zurich's models and processes.
The World Intellectual Property Indicators 2020 report covers 2019 data, predating the human and economic shock of the COVID-19 pandemic. What this year’s WIPI documents, however, is a strong foundation of IP activity that will serve as a base for new advancements as the pandemic subsides.
Ben Soffer, Head of Corporate Partnerships Kings College London presents ouon Corporate Partnerships.The MedTech Accelerator will act as a vehicle for the commercialisation of MedTech innovations. The Accelerator will be set up as a limited company based on a shareholder agreement and, in parallel, the parties are looking to facilitate the creation of a venture fund. The Accelerator has the ambition to position itself as the best place in the UK for MedTech Innovation to flourish successfully.
Valorisation of scientific results Patent commercialisation scoreboard: European universities and PROs”, finds that licensing is by far the preferred channel of commercialisation (accounting for 70% of the commercialisation of inventions), followed by R&D co-operation (14%) and the sale of patents (9%).
Andrew Katz will explore the dynamics of open technologies, and consider whether open hardware has the potential to be as successful as open source software.
Join our newsletter and get the latest news